Literature DB >> 25875151

Laparoscopic surgery for colorectal cancer is not associated with an increase in the circulating levels of several inflammation-related factors.

Antonio Crucitti1, Maddalena Corbi, Pasquina Mc Tomaiuolo, Caterina Fanali, Andrea Mazzari, Donatella Lucchetti, Mario Migaldi, Alessandro Sgambato.   

Abstract

It has been hypothesized that inflammatory response triggered by surgery might induce the release of molecules that could promote proliferation, invasion and metastasis of surviving cancer cells. To test this hypothesis, the levels of multiple inflammation-related circulating factors were analyzed in patients undergoing surgery for colorectal cancer. A Luminex xMAP system was used to simultaneously assess levels of IL-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL-17, FGF, eotaxin, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1, MIP-1α, MIP-1β, PDGF-BB, RANTES, TNF-α and VEGF in 20 colorectal cancer patients and 10 age-matched non-neoplastic patients. In cancer patients analyses were performed at baseline (before surgery) and at different time points (up to 30 days) following laparoscopic surgery. Significantly higher levels of IL-1β, IL-7, IL-8, G-CSF, IFN-γ and TNF-α were detected in colorectal cancer patients compared to controls at baseline. In colorectal cancer patients, circulating levels decreased progressively following surgery and after day 30 post-surgery were no longer different from controls. These findings suggest that expression levels of several cytokines are higher in colorectal cancer patients compared to control subjects and no significant increase in several inflammation-related circulating factors is observed following laparoscopic surgery for cancer. Confirmation and validation in a different and larger cohort of patients are warranted.

Entities:  

Keywords:  CRC, Colorectal Cancer.; CSC, Cancer Stem Cells; EMT, Epithelial Mesenchymal Transition; FGF-b, Fibroblast Growth Factor-basic; G-CSF, Granulocyte Colony Stimulating Factor; HuMCP-1, Human Monocyte Chemoattractant Protein 1; IFN-γ, Interferon γ; IL, Interleukin; IP-10, IFN-γ; Inducible Protein 10; Luminex xMAP; MIP-1α; Normal T-cell Expressed Secreted; PDGF-BB, Platelet Derived Growth Factor-BB; RANTES, Regulated upon Activation; Ra, Receptor antagonist; TNF-α, Tumor Necrosis Factor-α; VEGF, Vascular Endotelial Growth Factor; and 1β; and 1β, Macrophage Inflammatory Protein 1α; cancer biology; colon cancer; cytokines; inflammation; serum markers; surgery

Mesh:

Substances:

Year:  2015        PMID: 25875151      PMCID: PMC4622611          DOI: 10.1080/15384047.2015.1026476

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  31 in total

Review 1.  Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis.

Authors:  Vivian F Zhu; Jingxuan Yang; Drake G Lebrun; Min Li
Journal:  Cancer Lett       Date:  2011-11-07       Impact factor: 8.679

Review 2.  Development and maintenance of cancer stem cells under chronic inflammation.

Authors:  Toshihiko Tanno; William Matsui
Journal:  J Nippon Med Sch       Date:  2011       Impact factor: 0.920

3.  The relationship among acute-phase responce proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic.

Authors:  Ozgur Kemik; A S Kemik; H Begenik; F M Erdur; H Emre; A Sumer; S Purisa; S Tuzun; C Kotan
Journal:  Hum Exp Toxicol       Date:  2011-07-29       Impact factor: 2.903

Review 4.  Cancer-related inflammation.

Authors:  Juliana Candido; Thorsten Hagemann
Journal:  J Clin Immunol       Date:  2012-12-09       Impact factor: 8.317

Review 5.  Understanding the cancer stem cell.

Authors:  S Bomken; K Fiser; O Heidenreich; J Vormoor
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

Review 6.  The structural network of inflammation and cancer: merits and challenges.

Authors:  Emine Guven Maiorov; Ozlem Keskin; Attila Gursoy; Ruth Nussinov
Journal:  Semin Cancer Biol       Date:  2013-05-24       Impact factor: 15.707

7.  Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance.

Authors:  Malgorzata Krzystek-Korpacka; Dorota Diakowska; Bartosz Kapturkiewicz; Marek Bębenek; Andrzej Gamian
Journal:  Cancer Lett       Date:  2013-05-29       Impact factor: 8.679

8.  Regulation of cancer stem cell activities by tumor-associated macrophages.

Authors:  Masahisa Jinushi; Muhammad Baghdadi; Shigeki Chiba; Hironori Yoshiyama
Journal:  Am J Cancer Res       Date:  2012-08-20       Impact factor: 6.166

Review 9.  Chronic inflammation and cytokines in the tumor microenvironment.

Authors:  Glauben Landskron; Marjorie De la Fuente; Peti Thuwajit; Chanitra Thuwajit; Marcela A Hermoso
Journal:  J Immunol Res       Date:  2014-05-13       Impact factor: 4.818

10.  The NF-κB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1β.

Authors:  Pawan Kaler; Bramara N Godasi; Leonard Augenlicht; Lidija Klampfer
Journal:  Cancer Microenviron       Date:  2009-09-25
View more
  16 in total

1.  Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PD.

Authors:  Hiromichi Maeda; Ken-Ichi Okada; Tsutomu Fujii; Mari S Oba; Manabu Kawai; Seiko Hirono; Yasuhiro Kodera; Masayuki Sho; Takahiro Akahori; Yasuhiro Shimizu; Yoshiyasu Ambo; Naru Kondo; Yoshiaki Murakami; Jiro Ohuchida; Hidetoshi Eguchi; Hiroaki Nagano; Junichi Sakamoto; Hiroki Yamaue
Journal:  Oncol Lett       Date:  2018-09-07       Impact factor: 2.967

Review 2.  Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects.

Authors:  Yuval Shaked
Journal:  Nat Rev Clin Oncol       Date:  2016-04-26       Impact factor: 66.675

Review 3.  The pro-tumorigenic host response to cancer therapies.

Authors:  Yuval Shaked
Journal:  Nat Rev Cancer       Date:  2019-10-23       Impact factor: 60.716

4.  Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis.

Authors:  Jianxia Hu; Gang Zhao; Lize Zhang; Cuixia Qiao; Aiping Di; Hong Gao; Hong Xu
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

5.  Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon.

Authors:  Malgorzata Krzystek-Korpacka; Marek Zawadzki; Katarzyna Neubauer; Iwona Bednarz-Misa; Sabina Górska; Jerzy Wiśniewski; Wojciech Witkiewicz; Andrzej Gamian
Journal:  Cancer Immunol Immunother       Date:  2016-11-19       Impact factor: 6.968

6.  Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Inflammatory Markers in Colorectal Cancer Surgery: A Prospective Cohort Study.

Authors:  Lovorka Ðerek; Dražen Servis; Adriana Unić
Journal:  Chin Med J (Engl)       Date:  2017-11-20       Impact factor: 2.628

7.  Plasma cytokine levels and the presence of colorectal cancer.

Authors:  Masaki Yamaguchi; Shin Okamura; Taiki Yamaji; Motoki Iwasaki; Shoichiro Tsugane; Vivek Shetty; Tomonobu Koizumi
Journal:  PLoS One       Date:  2019-03-18       Impact factor: 3.240

8.  Local and Systemic IL-7 Concentration in Gastrointestinal-Tract Cancers.

Authors:  Iwona Bednarz-Misa; Dorota Diakowska; Małgorzata Krzystek-Korpacka
Journal:  Medicina (Kaunas)       Date:  2019-06-10       Impact factor: 2.430

Review 9.  Biomarkers for Evaluating the Inflammation Status in Patients with Cancer.

Authors:  Ali Guner; Hyoung-Il Kim
Journal:  J Gastric Cancer       Date:  2019-09-09       Impact factor: 3.720

10.  Ginseng berry concentrate prevents colon cancer via cell cycle, apoptosis regulation, and inflammation-linked Th17 cell differentiation.

Authors:  C-Z Wang; C Wan; Y Luo; C-F Zhang; Q-H Zhang; L Chen; C W Park; S H Kim; Z Liu; M Lager; M Xu; L Hou; C-S Yuan
Journal:  J Physiol Pharmacol       Date:  2021-08-06       Impact factor: 3.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.